Ameriprise Financial Inc Novo Cure LTD Transaction History

Ameriprise Financial Inc

$356 Billion
Q1 2025

A detailed history of Ameriprise Financial Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Ameriprise Financial Inc holds 22,118 shares of NVCR stock, worth $376,006. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,118

Previous 22,883 3.34%

Holding current value

$376,006

Previous $681,000 42.14%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$17.82 - $30.19 $13,632 - $23,095	-765 Reduced 3.34%	22,118 $394,000
Q4 2024 Feb 14, 2025	BUY	$14.54 - $33.41 $145,501 - $334,333	10,007 Added 77.72%	22,883 $681,000
Q3 2024 Nov 14, 2024	SELL	$15.61 - $23.34 $5,385 - $8,052	-345 Reduced 2.61%	12,876 $201,000
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $57,635 - $117,171	-4,872 Reduced 26.93%	13,221 $226,000
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $84,555 - $117,710	6,808 Added 60.33%	18,093 $282,000
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $125,602 - $178,077	11,285 New	11,285 $168,000
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $45,688 - $93,566	-1,134 Reduced 12.15%	8,196 $340,000
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $68,743 - $144,710	-1,218 Reduced 11.55%	9,330 $561,000
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $209,726 - $279,842	3,278 Added 45.09%	10,548 $773,000
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $226,542 - $298,447	-3,332 Reduced 31.43%	7,270 $553,000
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $80,655 - $128,107	-1,425 Reduced 11.85%	10,602 $736,000
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $4.44 Million - $6.24 Million	-73,802 Reduced 85.99%	12,027 $979,000
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $5.47 Million - $8.89 Million	72,842 Added 560.88%	85,829 $6.41 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $421,000 - $705,049	-3,624 Reduced 21.82%	12,987 $1.51 Million
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $115,404 - $199,638	885 Added 5.63%	16,611 $3.69 Million
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $591,632 - $906,540	-4,767 Reduced 23.26%	15,726 $2.08 Million
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $1.22 Million - $1.89 Million	10,879 Added 113.16%	20,493 $3.55 Million
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $4.78 Million - $9.17 Million	-82,385 Reduced 89.55%	9,614 $1.07 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $3.77 Million - $4.9 Million	65,888 Added 252.34%	91,999 $5.46 Million
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $385,658 - $647,270	-6,760 Reduced 20.57%	26,111 $1.76 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $109,758 - $150,736	-1,607 Reduced 4.66%	32,871 $2.77 Million
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $1.49 Million - $2.36 Million	-24,133 Reduced 41.17%	34,478 $2.58 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $2.47 Million - $3.71 Million	58,611 New	58,611 $3.71 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $2.19 Million - $4.02 Million	-76,310 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $572,256 - $937,069	-17,883 Reduced 18.99%	76,310 $4.01 Million
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $929,178 - $1.5 Million	46,810 Added 98.79%	94,193 $2.95 Million
Q1 2018 May 15, 2018	SELL	$19.3 - $23.65 $486,109 - $595,672	-25,187 Reduced 34.71%	47,383 $1.03 Million
Q4 2017 Feb 12, 2018	BUY	$16.3 - $21.9 $227,548 - $305,724	13,960 Added 23.82%	72,570 $1.47 Million
Q3 2017 Nov 07, 2017	BUY	$18.05 - $21.75 $1.06 Million - $1.27 Million	58,610	58,610 $1.16 Million

Others Institutions Holding NVCR

# of Institutions

266

Shares Held

79.4M

Call Options Held

970K

Put Options Held

118K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.78B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Novo Cure LTD Transaction History